| __timestamp | MiMedx Group, Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 105558000 | 27632226 |
| Thursday, January 1, 2015 | 167094000 | 97707000 |
| Friday, January 1, 2016 | 212608000 | 129037000 |
| Sunday, January 1, 2017 | 285920000 | 151332000 |
| Monday, January 1, 2018 | 322725000 | 158719000 |
| Tuesday, January 1, 2019 | 256174000 | 170104000 |
| Wednesday, January 1, 2020 | 208904000 | 192195000 |
| Friday, January 1, 2021 | 215332000 | 220706000 |
| Saturday, January 1, 2022 | 219525000 | 204426000 |
| Sunday, January 1, 2023 | 266843000 | 133788000 |
Data in motion
In the competitive landscape of biotechnology, understanding financial health is crucial. This analysis compares the gross profit trends of Travere Therapeutics, Inc. and MiMedx Group, Inc. from 2014 to 2023. Over this period, MiMedx Group, Inc. consistently outperformed Travere Therapeutics, Inc., with an average gross profit approximately 52% higher. Notably, MiMedx peaked in 2018, achieving a gross profit of over 320 million, while Travere's highest was in 2021, reaching around 221 million. However, Travere showed a remarkable growth trajectory, increasing its gross profit by nearly 700% from 2014 to 2021. In contrast, MiMedx experienced fluctuations, with a notable dip in 2019. These trends highlight the dynamic nature of the biotech industry, where strategic decisions and market conditions can significantly impact financial outcomes.
Gross Profit Trends Compared: Novo Nordisk A/S vs Travere Therapeutics, Inc.
Key Insights on Gross Profit: Sanofi vs Travere Therapeutics, Inc.
Bristol-Myers Squibb Company vs MiMedx Group, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Vertex Pharmaceuticals Incorporated and MiMedx Group, Inc.
Zoetis Inc. vs Travere Therapeutics, Inc.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Incyte Corporation or Travere Therapeutics, Inc.
Gross Profit Comparison: Bio-Techne Corporation and Travere Therapeutics, Inc. Trends
Alkermes plc vs MiMedx Group, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Amneal Pharmaceuticals, Inc. and MiMedx Group, Inc.
HUTCHMED (China) Limited and Travere Therapeutics, Inc.: A Detailed Gross Profit Analysis
Travere Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Selling, General, and Administrative Costs: Travere Therapeutics, Inc. vs MiMedx Group, Inc.